Predictors of severe immune-related adverse events during first-line immune checkpoint inhibitor therapy for advanced non-small cell lung cancer

O Olajumoke A. Olateju R Rajender R. Aparasu M Meera Patel T Tyler J. Varisco C Chan Shen M Meghana Trivedi E Ekere J. Essien J J. Douglas Thornton

Article Details

Volume / Issue Vol. 16, Issue 1
Published April 04, 2026
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (8)

O

Olajumoke A. Olateju

R

Rajender R. Aparasu

M

Meera Patel

T

Tyler J. Varisco

C

Chan Shen

M

Meghana Trivedi

E

Ekere J. Essien

J

J. Douglas Thornton